Analysts Viewpoint Adverum Biotechnologies Inc (ADVM) rating initates by Oppenheimer Adverum Biotechnologies Inc’s recent filing unveils that its CHIEF OPERATING OFFICER Soparkar Peter unloaded Company’s shares for reported $5920.0 on
Insiders Updates Adverum Biotechnologies Inc [NASDAQ: ADVM] Sees Decrease in Stock Value The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Featured Is Adverum Biotechnology, Inc (ADVM) stock Doomed to Fail? Adverum Biotechnologies, Inc. (ADVM) was subject to a 6.49% drop in share price on April 9th, 2021, now sitting at